English
English Español Português 日本

Articles

Article

When structure and symptoms don’t align

Optometry Times
May 2026
Every day, eyecare providers wonder: Does my patient have glaucoma? Dr. Frances Bynum highlights how insights from her RETeval ERG added clarity to a glaucoma suspect case and helped avoid overtreatment.
Read Now
Article

Ametek Acquires LKC Technologies

Retinal Physician
February 2026
LKC Technologies, known for its handheld ERG systems used to assess retinal function in-office, has been acquired by AMETEK as part of a strategic move to expand their ophthalmic portfolio. The acquisition complements AMETEK's existing eyecare diagnostics business, including Reichert.
Read Now
Article

Expanding ERG in Diabetic Eye Care

The Ophthalmologist
November 2025
Handheld ERG provides early functional insights in diabetic retinopathy and integrates seamlessly into clinic workflow. Recent evidence shows the RETeval DR Score is the strongest predictor of progression to vision-threatening complications, enabling more proactive, personalized care.
Read Now
Article

What to Do When Fields and OCT are Inconclusive: A Case Report

Eyes on Eyecare
September 2025
Glaucoma suspects often present a challenge. When a patient with existing DR was referred for suspected glaucoma, optometrist Mike Cymbor began with visual fields, OCT, and OCT-A. When those tests failed to provide conclusive results, Dr. Cymbor reached for his RETeval handheld ERG.
Read Now
Article

Glaucoma: Diagnostic Device Homeruns

Optometric Management
June 2025
Dr. Mike Cymbor shares the diagnostic technologies he considers key tools in glaucoma care. He highlights how devices like ERG and OCTs enhance clinical decision-making, especially in advanced or complex cases.
Read Now
LKC_AMETEK_website_logo_RGB_color
© 2026 LKC Technologies, Inc.

California Proposition 65 information

Prop-65Warning: This product can expose you to chemicals including lead, which is known to the State of California to cause cancer and birth defects or other reproductive harm. For more information go to www.P65Warnings.ca.gov.

Substance Tables:

The table below lists substances which may be contained within LKC’s RETeval and RETevet products. Substances listed as Type 1 are within permissible levels in one or more of LKC’s products. Substances listed as Type 2 are used in the production of some components used in LKC products and may be present at trace levels, but are typically destroyed during processing. 

RETeval and RETevet Devices

Substance CAS # Type Listed as causing:
Nickel 7440-02-0 1 Cancer
Acrylonitrile 107-13-1 2
Ethylbenzine 100-41-4 2
Crystaline Silica 14808-60-7 1
Lead 7439-92-1 1 Cancer Developmental Toxicity Male Reproductive Toxicity Female Reproductive Toxicity
Methylene Chloride 75-09-2 2 Cancer Female Reproductive Toxicity
Bisphenol A 80-05-7 2
N-Hexane  110-54-3 2 Male Reproductive Toxicity